Merck & Co. Inc. buy Barclays PLC
Start price
02.02.24
/
50%
€116.60
Target price
02.02.25
€134.11
Performance (%)
-18.18%
End price
03.02.25
€95.40
Summary
This prediction ended on 03.02.25 with a price of €95.40. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.18%. Dividends of €2.89 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 1.198% | 1.198% | -11.518% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Barclays PLC from $135.00 to $145.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€98.90
07.10.24
07.10.24
€127.58
07.10.25
07.10.25
-23.46%
08.10.25
08.10.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.14
31.07.25
31.07.25
-34.80%
01.08.25
01.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€108.20
23.01.24
23.01.24
€124.16
23.01.25
23.01.25
-14.23%
24.01.25
24.01.25